Market Research Logo

Biopharmaceutical and Vaccine Production Markets (Mammalian Cell Production, Microbial Cell Production Market, Monoclonal Antibody Manufacturing, Other Recombinant Protein Manufacturing, Vaccine Manufacturing, Insulin Manufacturing Market)


Attention: There is an updated edition available for this report.

Biopharmaceutical and Vaccine Production Markets

Biopharmaceutical and Vaccine Production Markets analyzes the entire manufacturing market for biologic drugs, including both outsourcing and costs by major maufacturers spending internally on biopharmaceutical and vaccine production.

As part of its coverage, the following information is provided

  • Market Size and Projections
  • Vaccine Manufacturing Estimates
  • Biologic Drug Methods
  • Trend Analysis
  • Types of Production
  • Outsourcing Market
  • Regulation of the Market
  • Competitor Profiles
This study contains production segmentations for the mammalian cell, microbial cell, monoclonal antibody, other recombinant protein, vaccine, and insulin manufacturing markets, with forecasts to 2018. Today's market environment is noted, listing selected biopharmaceutical contract manufacturers, selected top-selling biopharmaceuticals, selected Asian biomanufacturing contract manufacturing organizations (CMOs), the top 10 biopharma companies, and the top manufacturers by global biopharmaceutical manufacturing capacity.

This report profiles major drug makers and contract manufacturers:
  • Novartis
  • Pfizer
  • Sanofi Pasteur
  • A-Bio Pharma Pte Ltd.
  • ABL, Inc.
  • Affinity Life Sciences, Inc.
  • Ajinomoto Aminoscience, LLC
  • Alliance Medical Products, Inc.
  • Alpha Biologics
  • Biotecnol
  • Boston Mountain Biotech
  • Glycobia
  • Sutro Biopharma
  • ProBioGen AG
  • Baxter BioPharma Solutions/Baxter Bioscience
  • Genentech/Roche
  • AbbVie Inc. (Abbott)
  • Biogen Idec
  • Regeneron Pharmaceuticals
  • Alexion Pharmaceuticals
  • Crucell /Johnson & Johnson
  • GlaxoSmithKline
  • Merck & Co. Inc
  • Lonza AG
  • Boehringer Ingelheim GmbH
  • FUJIFILM Diosynth Biotechnologies
  • Sandoz
  • Royal DSM
  • Rentschler Biotechnologie
  • Celonic
  • BIOMEVA GmbH


Biopharmaceutical Manufacturing Services Market Reaches 36.8 Billion Kalorama

New York, September 15, 2014 — The total biopharmaceutical manufacturing market is growing, according to Kalorama Information’s report, Biopharmaceutical and Vaccine Production Markets. The market research publisher includes all costs related to biopharmaceutical and vaccine manufacturing in its estimates. The total global market equaled approximately $36.8 billion in 2013, with the high expense of adding biomanufacturing capacity at commercial production levels driving demand for specialized contract manufacturing, which is expected to grow due to new drug commercialization, recovered investment funding rates for biotechnology companies, and expanding service offerings for novel therapeutics.

“At this cost level, novel technologies and outsourcing are essential to strategy,” said Bruce Carlson, Publisher of Kalorama Information. “Fortunately, this means a lot of opportunity for companies that can service these needs.”

The market research publisher’s report contains production segmentations for the mammalian cell, microbial cell, monoclonal antibody, other recombinant protein, vaccine, and insulin manufacturing markets, with forecasts to 2018. Despite the proliferation of novel production technologies, commercial scale systems based on the familiar mammalian cells and E. coli are expected to continue to dominate the manufacturing scene through the end of 2018.

Biopharmaceutical and Vaccine Production Markets notes the current competitive environment, listing selected biopharmaceutical contract manufacturers, selected top-selling biopharmaceuticals, selected Asian biomanufacturing contract manufacturing organizations (CMOs), the top 10 biopharma companies based on 2012 biopharma revenues, and the top manufacturers by global biopharmaceutical manufacturing capacity. Profiles of key competitors are also included. The report can be found at: www.kaloramainformation.com/

About Kalorama Information -- Kalorama Information, a division of MarketResearch.com, supplies the latest in independent medical market research in diagnostics, biotech, pharmaceuticals, medical devices and healthcare; as well as a full range of custom research services. We routinely assist the media with healthcare topics. Follow us on Twitter, LinkedIn and our blog at www.kaloramainformation.com.

  • Executive Summary
    • MAJOR KINDS OF BIOPHARMACEUTICALS
      • Table Indications for Biologic Class (Erythropoietin, Interferon , Interferon , Monoclonal Antibody, Colony Stimulating Factors, Glucocerebrosidase), Partial
      • Monoclonal Antibodies
        • Table FDA-Approved Therapeutic Monoclonal Antibodies
      • Recombinant Proteins
      • Vaccines
        • Table Vaccine-Preventable Diseases, 2014
        • Table Major Vaccine Manufacturers
      • Insulins Insulins
      • Other Biopharm Protein Products
    • APPROVED BIOPHARMACEUTICAL PRODUCTS
      • Table 2014 Biological License Application Approvals
      • Table 2013 Biological License Application Approvals
      • Table 2013 Biological New Drug Application (NDA) and Abbreviated New Drug Application (ANDA) Approvals
    • BIOSIMILARS
  • Commercial Production
    • PROCESS OVERVIEW
      • Table Biopharma Manufacturing Process Overview
    • PRODUCTION SYSTEMS
      • Table Systems for the Production of Biopharmaceuticals
    • CELL CULTURE
      • Microbial Cells
      • Mammalian Cell Lines
      • Plant Cell Cultures
      • Insect Cells
    • TRANSGENICS
      • Transgenic Plants
      • Transgenic Animals
    • CELL-FREE PROTEIN PRODUCTION
  • Forecasts
    • TOTAL BIOPHARMACEUTICAL MANUFACTURING COSTS
      • Table Total Biopharmaceutical Manufacturing Market, 2012-2018 ($ billions; %)
      • Table Mammalian Cell Production Market, 2012-2018 ($ billions; %)
      • Table Microbial Cell Production Market, 2012-2018 ($ billions; %)
      • Table Monoclonal Antibody Manufacturing Market, 2012-2018 ($ billions; %)
      • Table Other Recombinant Proteins, Manufacturing Market, 2012-2018 ($ billions; %)
      • Table Vaccine Manufacturing Market, 2012-2018 ($ billions; %)
      • Table Insulin Manufacturing Market, 2012-2018 ($ billions; %)
  • Regulation
    • FDA-CBER
      • Allergenics
      • Blood and Blood Products
      • Cellular and Gene Therapy Products
      • Tissue and Tissue Products
      • Vaccines
    • EMA
  • Competitive Environment
    • ORIGINATOR AND CONTRACT MANUFACTURING
      • Outsourcing
        • Table List of Selected Biopharmaceutical Contract Manufacturers
    • TYPES OF CONTRACTORS INVOLVED IN BIOMANUFACTURING
    • DEMAND FOR BIOPHARMACEUTICAL MANUFACTURING INCREASING
      • Table Selected Top-Selling Biopharmaceuticals, 2013
    • PRODUCTION CAPACITY FOR BIOPHARMACEUTICAL MANUFACTURING
    • ALTERNATIVE METHODS OF PRODUCING BIOPHARMACEUTICALS
      • CMOs Expanding Operations to Manufacture Biologics
    • BIOMANUFACTURING IN ASIA
      • Table Selected Asia Biomanufacturing CMOs
    • TOP MANUFACTURERS
      • Integrated R&D, Manufacturing Firms
        • Table Top 10 Biopharma Companies Based on 2012 Biopharma Revenues ($ millions)
        • Table Top Manufacturers by Global Biopharmaceutical Manufacturing Capacity
    • MERGER AND ACQUISITION ACTIVITY
      • Table Top Pharmaceutical Acquisitions in 2013
      • Table Top Ten Pharmaceutical Acquisitions in 2012
    • LICENSING AND COLLABORATIONS
      • Table Biopharmaceutical Licensing and Collaboartions in 2013
  • Patents
    • SELECT MAMMALIAN, YEAST, INSECT, PLANT, AND TRANSGENIC PATENTS
      • Table Selected Biopharmaceutical Manufacturing Patents Granted between January 1, 2013 and July 15, 2014 – Mammal
      • Table Selected Biopharmaceutical Manufacturing Patents Granted between January 1, 2013 and July 15, 2014 – Yeast
      • Table Selected Biopharmaceutical Manufacturing Patents Granted between January 1, 2013 and July 15, 2014 – Insect
      • Table Selected Biopharmaceutical Manufacturing Patents Granted between January 1, 2013 and July 15, 2014 – Plant
      • Table Selected Biopharmaceutical Manufacturing Patents Granted between January 1, 2013 and July 15, 2014 – Transgenic
    • E. COLI PATENTS
      • Table Selected Biopharmaceutical Manufacturing Patents Granted between January 1, 2013 and July 15, 2014 - E. coli
  • Geography
    • Table Estimated Biopharmaceutical Manufacturing Capacity by Region, 2014, by Revenues (%)
  • Profiles
    • MAJOR CONTRACT MANUFACTURERS
      • Lonza AG
      • Boehringer Ingelheim GmbH
      • FUJIFILM Diosynth Biotechnologies
      • Sandoz
      • Royal DSM
      • Rentschler Biotechnologie
      • Celonic
      • BIOMEVA GmbH
      • ProBioGen AG
      • Baxter BioPharma Solutions/Baxter Bioscience
    • MAJOR BIOLOGICS FIRMS
      • Amgen
      • Genentech/Roche
      • AbbVie Inc. (Abbott)
      • Biogen Idec
      • Regeneron Pharmaceuticals
      • Alexion Pharmaceuticals
      • Crucell /Johnson & Johnson
      • GlaxoSmithKline
      • Merck & Co. Inc Merck & Co. Inc
      • Novartis
      • Pfizer
      • Sanofi Pasteur
    • OTHER CONTRACT MANUFACTURERS
      • AAIPharma
      • A-Bio Pharma Pte Ltd.
      • ABL, Inc.
      • Affinity Life Sciences, Inc.
      • Ajinomoto Aminoscience, LLC
      • Alliance Medical Products, Inc.
      • Alpha Biologics
      • Biotecnol
      • Boston Mountain Biotech
      • Glycobia
      • Sutro Biopharma

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report